Myriad Genetics (MYGN) announced that the United States Patent ... MRD methods that are performed via an automation system configured to interface with laboratory equipment. U.S. patent No. 12,215,392 ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

Trilobio was founded to improve genetic engineering, synthetic biology and life science research processes by building robotic lab automation modules coupled with an application store to package ...

In 2024, Myriad Genetics was awarded three patents related to foundational platform MRD technology and cell-free DNA preparation methods that each enable highly sensitive and specific tumor-informed, ...